Aug. 28 at 4:33 PM
$VERA Ok I'm in!!! Thanks to those that recommended it over the weekend and I am blown away! Had to take a few coins from
$SLS for now -- if you rock with me i'd suggest you look at
$VERA this weekend they are in the IgAN space -- go ahead and lock up 100 or 1 share so you don't forget .... POSSIBLE
$100+ and NEXT MONTH is the finale
==============
Travere Therapeutics (
$TVTX):
$6.06 billion to
$6.19 billion (Maker of Filspari, a major commercial direct competitor in the IgAN space).
Calliditas Therapeutics (Acquired by Asahi Kasei): Estimated around
$1.1 billion (Pioneer and market holder of Tarpeyo, the first FDA-approved targeted IgAN treatment).
Novartis (
$NVS):
$250+ billion (The pharma giant holding major positioning in the renal/immunology space with Fabhalta).
